Approvals/CIMA-AEMPS/DOBUTAMINA HIKMA 12,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

DOBUTAMINA HIKMA 12,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Hikma Farmaceutica (Portugal) S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 224a15e7dbe2c7ad
Drug Cima Aemps Name: DOBUTAMINA HIKMA 12,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number: 85914
Holder Company Name: Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name: Hikma España, S.L.U.
Holder Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a
Authorization Date: 2021-04-14
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 12.5 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Hikma Farmaceutica (Portugal) S.A.
Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a

DOBUTAMINA HIDROCLORURO

14,01 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 14, 2021

Approval ID

224a15e7dbe2c7ad

Type

Standard